Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical oxybutynin versus oral fesoterodine in children with neurogenic detrusor overactivity
2012-005295-33Phase 3Completed
- Sponsor
- UZ Leuven
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fesoterodine in detrusor hyperreflexia (DH), spina bifida (SB), sponsored by UZ Leuven. Started Dec 2012; status: completed.
02
Drugs
fesoterodine
03
Conditions
detrusor hyperreflexia (DH)spina bifida (SB)
Beyond the preview
Go deeper on 2012-005295-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005295-33.